250 related articles for article (PubMed ID: 17339277)
1. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU.
Lee JH; Choi CH; Kang HY; Lee JY; Kim J; Lee YC; Seol SY; Cho DT; Kim KW; Song DY; Lee JC
J Antimicrob Chemother; 2007 Apr; 59(4):633-9. PubMed ID: 17339277
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
3. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
4. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
5. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance determinants in imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii complex isolated in Daejeon, Korea.
Sung JY; Kwon KC; Cho HH; Koo SH
Korean J Lab Med; 2011 Oct; 31(4):265-70. PubMed ID: 22016680
[TBL] [Abstract][Full Text] [Related]
7. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
[TBL] [Abstract][Full Text] [Related]
8. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
9. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates.
Lim YM; Shin KS; Kim J
J Clin Microbiol; 2007 Mar; 45(3):902-5. PubMed ID: 17192417
[TBL] [Abstract][Full Text] [Related]
10. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH
J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182.
Kim CK; Lee Y; Lee H; Woo GJ; Song W; Kim MN; Lee WG; Jeong SH; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):432-8. PubMed ID: 20884158
[TBL] [Abstract][Full Text] [Related]
12. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
[TBL] [Abstract][Full Text] [Related]
13. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea.
Park YK; Lee GH; Baek JY; Chung DR; Peck KR; Song JH; Ko KS
Microb Drug Resist; 2010 Jun; 16(2):143-9. PubMed ID: 20370437
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary investigation of the molecular mechanisms of imipenem-resistance in clinical isolates of Acinetobacter baumannii in Xi'an].
Tan XS; Liu Y; Han XP
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1393-6. PubMed ID: 19620063
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
[TBL] [Abstract][Full Text] [Related]
16. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
17. Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.
Lin YC; Sheng WH; Chen YC; Chang SC; Hsia KC; Li SY
Int J Antimicrob Agents; 2010 May; 35(5):439-43. PubMed ID: 20106635
[TBL] [Abstract][Full Text] [Related]
18. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
[TBL] [Abstract][Full Text] [Related]
19. Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Yang HY; Lee HJ; Suh JT; Lee KM
Yonsei Med J; 2009 Dec; 50(6):764-70. PubMed ID: 20046415
[TBL] [Abstract][Full Text] [Related]
20. [Study on carbapenemase and 16S rRNA methylase of imipenem-resistant Acinetobacter baumannii].
Zhou H; Du XX; Yang Q; Zhou JY; Yu YS; Li LJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):269-72. PubMed ID: 19642384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
